1 / 1

CTLA-4

CTLA-4. Inhibitory signal. Inhibitory signal. Activator signal. SHP-1/2. PD1. Up “28 kinases”. Up “supervised list”. KIR. DAP10. Anti-tumor mediated activation. NKG2D. PLC- . Pi3K. Activation signal. 1. PIP(3-5)P3. CD28. LCK. Pyk2. TCR/NCR or BCR mediated activation. ZAP-70.

xander
Télécharger la présentation

CTLA-4

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CTLA-4 Inhibitory signal Inhibitory signal Activator signal SHP-1/2 PD1 Up “28 kinases” Up “supervised list” KIR DAP10 Anti-tumor mediated activation NKG2D PLC- Pi3K Activation signal 1 PIP(3-5)P3 CD28 LCK Pyk2 TCR/NCR or BCR mediated activation ZAP-70 Rho/ CDC42 Vav LCP2 FAK Syk Fyn TCR CD3 GADS LAT 2 CD3 Rac ERK1/2 Movement & granules exocytosis Proliferation Differentiation/cytotoxicity Immune response/Activation Grb2 ITK Apoptosis of targeted cells MAPK signaling pathway AP1 SOS RAS PLC- Cell survival PIM2 NFKB FASL RASGRP1/2 Bid CASP IKKa CARMA1 DAG PKC IKKg BCL10 IKB IKKb MALT1 PRF1, GZM, GNLY, CMK, FASL… Ca2+ signaling pathway CTK regulation Ca2+ release IP3 NFAT GZM PERF GZM Movement & exocytosis Cytokine mediated activation 3 CTK-R JAK-STAT signaling pathway IFNs-R TRAIL Figure S1

More Related